AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Christopher Conlon

Christopher Conlon i

University of Oxford - Oxford / United Kingdom
Medical and Health Sciences / Infectious Diseases
AD Scientific Index ID: 1573843
person_outline Christopher Conlon's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK The Lancet 397 (10269), 99-111, 2021
2-) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial The Lancet 396 (10249), 467-478, 2020
3-) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial The Lancet 396 (10267), 1979-1993, 2020
4-) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … The Lancet 397 (10277), 881-891, 2021
5-) Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Nature immunology 21 (11), 1336-1345, 2020